Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asian Phytoceuticals PCLBKK:APCO-R 62 Cash-to-Debt is 38.84 as of Mar. 2026, which is 6% above its 10-year median of 36.48. GuruFocus rates BKK:APCO-R with a GF Score™ of 62/100 and a GF Value™ of ฿7.13. The stock has 4 warning signs investors should review. Among 1,949 Consumer Packaged Goods companies, Asian Phytoceuticals PCL ranks better than 88.97% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Asian Phytoceuticals PCL's cash to debt ratio for the quarter that ended in Mar. 2026 was 38.84.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Asian Phytoceuticals PCLcould pay off its debt using the cash in hand for the quarter that ended in Mar. 2026.
The historical rank and industry rank for Asian Phytoceuticals PCL's Cash-to-Debt or its related term are showing as below:
BKK:APCO-R'
s Cash-to-Debt Range Over the Past 10 Years
Min: 3.39 Med: 36.48 Max: No Debt
Current: 38.84
During the past 13 years, Asian Phytoceuticals PCL's highest Cash to Debt Ratio was No Debt. The lowest was 3.39. And the median was 36.48.
BKK:APCO-R's Cash-to-Debt is ranked better than 88.97% of 1949
companies
in the Consumer Packaged Goods industry
Industry Median: 0.53
vs BKK:APCO-R: 38.84
Asian Phytoceuticals PCL (BKK:APCO-R) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Asian Phytoceuticals PCL Cash-to-Debt Related Terms
Asian Phytoceuticals PCL Cash-to-Debt Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BKK:APCO-R vs PG, CL, KVUE: Cash-to-Debt Comparison
For the Household & Personal Products subindustry, Asian Phytoceuticals PCL's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asian Phytoceuticals PCL Cash-to-Debt vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Asian Phytoceuticals PCL's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Asian Phytoceuticals PCL's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asian Phytoceuticals PCL (BKK:APCO-R) has a Cash-to-Debt of 38.84 as of Mar. 2026. This is near median its historical median of 36.48. Over the past decade, Asian Phytoceuticals PCL's Cash-to-Debt has ranged from 3.39 to 10,000.00. According to the industry distribution chart, Asian Phytoceuticals PCL ranks #215 out of 1949 companies in the Consumer Packaged Goods industry, placing it in the top 11%.
Is Asian Phytoceuticals PCL's Cash-to-Debt too high?
Asian Phytoceuticals PCL's current Cash-to-Debt of 38.84 is near median its 10-year median of 36.48. Over the past 10 years, this metric has ranged from a low of 3.39 to a high of 10,000.00. The Consumer Packaged Goods industry median Cash-to-Debt is 0.53. Asian Phytoceuticals PCL's value of 38.84 is 7228.3% above this industry median. Based on the distribution chart, Asian Phytoceuticals PCL ranks #215 out of 1949 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Asian Phytoceuticals PCL has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Asian Phytoceuticals PCL's Cash-to-Debt compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Asian Phytoceuticals PCL ranks #215 out of 1949 companies for Cash-to-Debt. This places Asian Phytoceuticals PCL in the top 11% of its industry — outperforming the majority of peers. The industry median Cash-to-Debt is 0.53. Asian Phytoceuticals PCL's value of 38.84 is 7228.3% above this benchmark. Historically, Asian Phytoceuticals PCL's own Cash-to-Debt has ranged from 3.39 to 10,000.00 over the past decade. While the company's 10-year median is 36.48 vs. the industry median of 0.53, Asian Phytoceuticals PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Consumer Packaged Goods company?
The median Cash-to-Debt among Consumer Packaged Goods companies is 0.53, based on 1,949 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asian Phytoceuticals PCL's current Cash-to-Debt of 38.84 is 7228.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median Cash-to-Debt is 0.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asian Phytoceuticals PCL's current Cash-to-Debt is 38.84, which is near median its own 10-year median of 36.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asian Phytoceuticals PCL stock overvalued right now?
Asian Phytoceuticals PCL (BKK:APCO-R) has a current Cash-to-Debt of 38.84. The stock's GF Value™ is ฿7.13, compared to a current price of ฿6.27 — trading 12% below its estimated fair value. The current Cash-to-Debt is 38.84, which is near median its 10-year median of 36.48 and 7228.3% above the Consumer Packaged Goods industry median of 0.53. Asian Phytoceuticals PCL's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Asian Phytoceuticals PCL (BKK:APCO-R), the current Cash-to-Debt is 38.84 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asian Phytoceuticals PCL (BKK:APCO-R) Overvalued in 2026?
Based on GuruFocus' analysis, Asian Phytoceuticals PCL stock appears to be undervalued.
The current stock price of ฿6.27 is trading 12% below its estimated GF Value™ of ฿7.13.
Key valuation signals for BKK:APCO-R:
Cash-to-Debt: 38.84 (near median its 10-year median of 36.48)
GF Value™: ฿7.13 vs. price of ฿6.27 (12% below fair value)
Industry Position: 7228.3% above the Consumer Packaged Goods median (#215 of 1949)
No single metric tells the full story. See the BKK:APCO-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asian Phytoceuticals PCL engages in the manufacturing and marketing of herbal healthcare products. The company engages in the production and distribution of dietary supplements, cosmetics, and personal care products made from natural herbs. Its beauty products include skin nourishing and skin care products, hair loss treatment and hair growth products, slimming products, dietary supplements, and other nutritional products. Geographically, the company offers its services only in Thailand.
62GF Score
Get the complete analysis for BKK:APCO-R
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:APCO-R has been successfully added to your 
